AC Immune’s (ACIU) “Buy” Rating Reaffirmed at HC Wainwright
HC Wainwright reiterated their buy rating on shares of AC Immune (NASDAQ:ACIU – Free Report) in a report published on Monday morning, Benzinga reports. HC Wainwright currently has a $16.00 target price on the stock. Separately, StockNews.com assumed coverage on shares of AC Immune in a research note on Thursday, October 5th. They set a […]
More Stories
DHS Secretary Says Southern Border Wall Will Be Painted Black to Deter Illegal Crossings
By Aldgra Fredly Homeland Security Secretary Kristi Noem said Aug. 19 that President Donald Trump has requested that the entire...
New Mexico’s 7-Day ‘Cooling Off’ Period for Gun Purchases is Unconstitutional, Appeals Court Rules
By Michael Clements New Mexico’s seven-day waiting period after the purchase of a gun was ruled unconstitutional by the U.S....
Rookie Isaac TeSlaa Stands Out in Lions Camp
By John Rigolizzo Detroit Lions general manager Brad Holmes had high praise for rookie wide receiver Isaac TeSlaa, who was...
Public Sector Pension Investment Board Raises Position in The Clorox Company $CLX
Public Sector Pension Investment Board raised its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 7.2%...
Swiss National Bank Cuts Stock Position in Curbline Properties Corp. $CURB
Swiss National Bank lowered its position in Curbline Properties Corp. (NYSE:CURB – Free Report) by 1.3% during the first quarter,...
IDACORP, Inc. $IDA Shares Sold by Russell Investments Group Ltd.
Russell Investments Group Ltd. lessened its holdings in shares of IDACORP, Inc. (NYSE:IDA – Free Report) by 24.4% during the...